‘Buy’ Nephrocare Health Services for 16% upside, says ICICI Securities; check share price target

Nephrocare Health Services appears to be set for significant growth, with ICICI Securities projecting impressive revenue and profit growth. The stock has jumped 64% year-to-date compared to a 12% drop in equity benchmark Sensex.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.